Episode Details
Back to Episodes
Pharmaceutical Executive Daily: Johnson & Johnson Separating Its Orthopedics Unit
Published 7 months ago
Description
In today’s Pharmaceutical Executive Daily, we explore Johnson & Johnson’s plan to separate its orthopaedics division into a standalone company, the global implications of the Most Favored Nation drug pricing proposal, and strategies helping small biotechs reach market faster.